Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer

Por Pinato, D J, Shiner, R J, Seckl, M J, Stebbing, J, Sharma, R, Mauri, F A
Publicado em 2014

The clinical applications of the cancer genome atlas project for bladder cancer

Por Creighton, Chad J.
Publicado no Expert Rev Anticancer Ther (2018)

Mechanisms of Cryoablation: Clinical Consequences on Malignant Tumors

Por Baust, J.G., Gage, A.A., Johansen, T.E. Bjerklund, Baust, J.M.
Publicado em 2013

Biclustering reveals breast cancer tumour subgroups with common clinical features and improves prediction of disease recurrence

Por Wang, Yi Kan, Print, Cristin G, Crampin, Edmund J
Publicado em 2013

Potential early clinical stage colorectal cancer diagnosis using a proteomics blood test panel

Por Ahn, Seong Beom, Sharma, Samridhi, Mohamedali, Abidali, Mahboob, Sadia, Redmond, William J., Pascovici, Dana, Wu, Jemma X., Zaw, Thiri, Adhikari, Subash, Vaibhav, Vineet, Nice, Edouard C., Baker, Mark S.
Publicado no Clin Proteomics (2019)

Assessing the clinical value of targeted massively parallel sequencing in a longitudinal, prospective population-based study of cancer patients

Por Wong, S Q, Fellowes, A, Doig, K, Ellul, J, Bosma, T J, Irwin, D, Vedururu, R, Tan, A Y-C, Weiss, J, Chan, K S, Lucas, M, Thomas, D M, Dobrovic, A, Parisot, J P, Fox, S B
Publicado no Br J Cancer (2015)

Prediction of response to pemetrexed in non-small-cell lung cancer with immunohistochemical phenotyping based on gene expression profiles

Por Visser, S., Hou, J., Bezemer, K., de Vogel, L. L., Hegmans, J. P. J. J., Stricker, B. H., Philipsen, S., Aerts, J. G. J. V.
Publicado no BMC Cancer (2019)

Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers

Por Nones, K, Johnson, J, Newell, F, Patch, A M, Thorne, H, Kazakoff, S H, de Luca, X M, Parsons, M T, Ferguson, K, Reid, L E, McCart Reed, A E, Srihari, S, Lakis, V, Davidson, A L, Mukhopadhyay, P, Holmes, O, Xu, Q, Wood, S, Leonard, C, Beesley, J, Harris, J M, Barnes, D, Degasperi, A, Ragan, M A, Spurdle, A B, Khanna, K K, Lakhani, S R, Pearson, J V, Nik-Zainal, S, Chenevix-Trench, G, Waddell, N, Simpson, P T
Publicado no Ann Oncol (2019)

Clinical Significance of Circulating Tumor Cells Detected by an Invasion Assay in Peripheral Blood of Patients with Ovarian Cancer

Por Fan, Tina, Zhao, Qiang, Chen, John J., Chen, Wen-Tien, Pearl, Michael L.
Publicado em 2008

Estimation of renal function and its potential impact on carboplatin dosing in children with cancer

Por Chinnaswamy, G, Cole, M, Boddy, A V, Keir, M, Price, L, Parry, A, English, M, Veal, G J
Publicado em 2008

Chemoproteomics reveals novel protein and lipid kinase targets of clinical CDK4/6 inhibitors in lung cancer

Por Sumi, Natalia J., Kuenzi, Brent M., Knezevic, Claire E., Rix, Lily L. Remsing, Rix, Uwe
Publicado no ACS Chem Biol (2015)

Prospective Comprehensive Genomic Profiling of Advanced Gastric Carcinoma Cases Reveals Frequent...

Por Ali, Siraj M., Sanford, Eric M., Klempner, Samuel J., Rubinson, Douglas A., Wang, Kai, Palma, Norma A., Chmielecki, Juliann, Yelensky, Roman, Palmer, Gary A., Morosini, Deborah, Lipson, Doron, Catenacci, Daniel V., Braiteh, Fadi, Erlich, Rachel, Stephens, Philip J., Ross, Jeffrey S., Ou, Sai-Hong Ignatius, Miller, Vincent A.
Publicado no Oncologist (2015)

A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer

Por Stoehlmacher, J, Park, D J, Zhang, W, Yang, D, Groshen, S, Zahedy, S, Lenz, H-J
Publicado em 2004

Are Allogeneic Blood Transfusions Associated With Decreased Survival After Surgery for Long-bone Metastatic Fractures?

Por Janssen, Stein J., Braun, Yvonne, Ready, John E., Raskin, Kevin A., Ferrone, Marco L., Hornicek, Francis J., Schwab, Joseph H.
Publicado no Clin Orthop Relat Res (2015)

Serum protein profiling reveals baseline and pharmacodynamic biomarker signatures associated...

Por Pommier, A J C, Shaw, R, Spencer, S K M, Morgan, S R, Hoff, P M, Robertson, J D, Barry, S T, Jürgensmeier, J M
Publicado em 2014

Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens

Por Prieto, DaRue A, Johann, Donald J, Wei, Bih-Rong, Ye, Xiaoying, Chan, King C, Nissley, Dwight V, Simpson, R Mark, Citrin, Deborah E, Mackall, Crystal L, Linehan, W Marston, Blonder, Josip
Publicado em 2014

Novel Monte Carlo approach quantifies data assemblage utility and reveals power of integrating molecular and clinical information for cancer prognosis

Por Verleyen, Wim, Langdon, Simon P., Faratian, Dana, Harrison, David J., Smith, V. Anne
Publicado no Sci Rep (2015)

The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers

Por Atherly, A J, Camidge, D R
Publicado em 2012

Next-generation sequencing reveals frequent consistent genomic alterations in small cell undifferentiated lung cancer

Por Ross, J S, Wang, K, Elkadi, O R, Tarasen, A, Foulke, L, Sheehan, C E, Otto, G A, Palmer, G, Yelensky, R, Lipson, D, Chmielecki, J, Ali, S M, Elvin, J, Morosini, D, Miller, V A, Stephens, P J
Publicado em 2014

High Prevalence and Clinical Relevance of Genes Affected by Chromosomal Breaks in Colorectal Cancer

Por van den Broek, Evert, Dijkstra, Maurits J. J., Krijgsman, Oscar, Sie, Daoud, Haan, Josien C., Traets, Joleen J. H., van de Wiel, Mark A., Nagtegaal, Iris D., Punt, Cornelis J. A., Carvalho, Beatriz, Ylstra, Bauke, Abeln, Sanne, Meijer, Gerrit A., Fijneman, Remond J. A.
Publicado no PLoS One (2015)